Overview

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the effects of oral psilocybin on OCD symptomatology and provide the first evidence of the neural mechanism that may mediate psilocybin's purported therapeutic effects on OCD.
Phase:
Phase 1
Details
Lead Sponsor:
Yale University
Collaborator:
Heffter Research Institute
Treatments:
Niacin
Niacinamide
Nicotinic Acids
Psilocybin